Stay updated on EAP Avapritinib in Advanced GIST Clinical Trial
Sign up to get notified when there's something new on the EAP Avapritinib in Advanced GIST Clinical Trial page.

Latest updates to the EAP Avapritinib in Advanced GIST Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has undergone significant content removal, including details about the Early Access Program for avapritinib, its inclusion and exclusion criteria, and the previous version number. The new version number is v2.15.0.SummaryDifference34%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check87 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check94 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
Stay in the know with updates to EAP Avapritinib in Advanced GIST Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EAP Avapritinib in Advanced GIST Clinical Trial page.